Immune mechanisms underlying delayed disease progression in HIV-1 and HIV-2 infection

HIV-1 和 HIV-2 感染延迟疾病进展的免疫机制

• 批准号: G0801751/1
• 负责人: Sarah Rowland-Jones
• 金额: $ 46.38万
• 依托单位: University of Oxford
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2008
• 资助国家: 英国
• 起止时间: 2008 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=G0801751%2F1
• 关键词: Immune; mechanisms; underlying; delayed; disease

In order to design an effective vaccine against HIV infection we need to know more about how the immune system can combat HIV infection in people who have controlled the virus naturally without the need for drugs. We plan to study two groups of people where there are a large number of HIV-infected subjects who have low virus levels in their blood many years after being first infected, in China and West Africa.

为了设计一种有效的抗艾滋病毒疫苗，我们需要更多地了解免疫系统如何在不需要药物的情况下自然控制病毒的人体内对抗艾滋病毒感染。我们计划在中国和西非研究两组人群，那里有大量hiv感染者，他们在首次感染多年后血液中的病毒水平很低。